- Report
- January 2024
- 183 Pages
Africa, Middle East
From €1386EUR$1,500USD£1,175GBP
- Report
- April 2025
- 153 Pages
Africa, Middle East
From €3187EUR$3,450USD£2,703GBP
- Report
- February 2024
- 180 Pages
Global
From €4110EUR$4,450USD£3,486GBP
- Report
- October 2024
- 264 Pages
Global
From €4110EUR$4,450USD£3,486GBP
- Report
- September 2024
- 94 Pages
North America
From €3187EUR$3,450USD£2,703GBP
- Report
- September 2024
- 94 Pages
Europe
From €3187EUR$3,450USD£2,703GBP
- Report
- September 2024
- 90 Pages
Asia Pacific
From €3187EUR$3,450USD£2,703GBP
- Report
- July 2024
Global
From €4572EUR$4,950USD£3,878GBP
- Report
- February 2026
- 100 Pages
Global
From €3500EUR$4,059USD£3,072GBP
The Antibody Discovery Services market is a segment of the biopharmaceuticals industry that focuses on the development of antibodies for therapeutic and diagnostic purposes. Antibody discovery services involve the identification and characterization of antibodies that can be used to target specific molecules or cells. This process typically involves the use of high-throughput screening techniques, such as phage display, to identify and isolate antibodies with desired properties. The antibodies can then be further characterized and optimized for use in therapeutic and diagnostic applications.
The Antibody Discovery Services market is driven by the increasing demand for therapeutic and diagnostic antibodies, as well as the need for more efficient and cost-effective methods for antibody discovery. Companies in this market include Abcam, Bio-Rad, Creative Biolabs, GenScript, and Sino Biological. Show Less Read more